<DOC>
	<DOCNO>NCT02872168</DOCNO>
	<brief_summary>Recent in-vitro in-vivo study perform one investigator ( ESO , ICMPE , UPEC , France ) recently allow synthetize new easy-to-synthesized chemical compound furosemide ( pyridinium furosemide ) furosemide degradation electro-Fenton bioconversion . The biological property pyridinium furosemide currently investigation . Furosemide diuretic currently use treatment patient heart failure . The goal investigator assay pyridinium furosemide urine patient treat furosemide demonstrate pyridinium metabolite furosemide human . This study contribute assess fate pharmaceutical residue furosemide environment .</brief_summary>
	<brief_title>Identification New Metabolite Furosemide Humans</brief_title>
	<detailed_description />
	<mesh_term>Furosemide</mesh_term>
	<criteria>1 . Age â‰¥ 18 year 2 . Written inform consent 3 . Affiliation social security 4 . Known heart failure 5 . Treatment furosemide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>